167 related articles for article (PubMed ID: 8433091)
1. Positron emission tomographic (PET) studies in dementia.
Goto I; Taniwaki T; Hosokawa S; Otsuka M; Ichiya Y; Ichimiya A
J Neurol Sci; 1993 Jan; 114(1):1-6. PubMed ID: 8433091
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomographic study in Alzheimer's disease and Pick's disease.
Salmon E; Franck G
Arch Gerontol Geriatr Suppl; 1989; 1():241-7. PubMed ID: 2787995
[TBL] [Abstract][Full Text] [Related]
3. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
Habert MO; Spampinato U; Mas JL; Piketty ML; Bourdel MC; de Recondo J; Rondot P; Askienazy S
Eur J Nucl Med; 1991; 18(1):3-11. PubMed ID: 2019279
[TBL] [Abstract][Full Text] [Related]
4. Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.
Sasaki M; Ichiya Y; Hosokawa S; Otsuka M; Kuwabara Y; Fukumura T; Kato M; Goto I; Masuda K
Ann Nucl Med; 1992 Nov; 6(4):241-6. PubMed ID: 1489634
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography in degenerative disorders of the dopaminergic system.
Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
[TBL] [Abstract][Full Text] [Related]
6. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography imaging of regional cerebral glucose metabolism.
Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
[TBL] [Abstract][Full Text] [Related]
8. Cerebral glucose metabolism in Parkinson's disease with and without dementia.
Peppard RF; Martin WR; Carr GD; Grochowski E; Schulzer M; Guttman M; McGeer PL; Phillips AG; Tsui JK; Calne DB
Arch Neurol; 1992 Dec; 49(12):1262-8. PubMed ID: 1449406
[TBL] [Abstract][Full Text] [Related]
9. [A study on the cerebral glucose metabolism in progressive supranuclear palsy].
Ma AJ; Guo XJ; Li DC; Zhang BS; Pan XD
Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):885-8. PubMed ID: 23291028
[TBL] [Abstract][Full Text] [Related]
10. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
Asahina M; Suhara T; Shinotoh H; Inoue O; Suzuki K; Hattori T
J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
[TBL] [Abstract][Full Text] [Related]
11. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
Kuhl DE; Metter EJ; Riege WH; Markham CH
Ann Neurol; 1984; 15 Suppl():S119-25. PubMed ID: 6234856
[TBL] [Abstract][Full Text] [Related]
12. Functional brain imaging in late-life depression and dementia.
Kumar A
J Clin Psychiatry; 1993 Nov; 54 Suppl():21-5. PubMed ID: 8270594
[TBL] [Abstract][Full Text] [Related]
13. Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy.
Otsuka M; Ichiya Y; Kuwabara Y; Miyake Y; Tahara T; Masuda K; Hosokawa S; Goto I; Kato M; Ichimiya A
Ann Nucl Med; 1989 Nov; 3(3):111-8. PubMed ID: 2641456
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in the differential diagnosis of organic dementias.
Heiss WD; Kessler J; Szelies B; Grond M; Fink G; Herholz K
J Neural Transm Suppl; 1991; 33():13-9. PubMed ID: 1753242
[TBL] [Abstract][Full Text] [Related]
15. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.
Garraux G; Salmon E; Degueldre C; Lemaire C; Laureys S; Franck G
Neuroimage; 1999 Aug; 10(2):149-62. PubMed ID: 10417247
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography in Creutzfeldt-Jakob disease.
Holthoff VA; Sandmann J; Pawlik G; Schröder R; Heiss WD
Arch Neurol; 1990 Sep; 47(9):1035-8. PubMed ID: 2204331
[TBL] [Abstract][Full Text] [Related]
17. [Brain glucose metabolism in a patient with Creutzfeldt-Jakob disease measured by positron emission tomography].
Shishido F; Uemura K; Inugami A; Tomura N; Higano S; Fujita H; Tabata K; Sasaki H; Murakami M; Kanno I
Kaku Igaku; 1990 Jun; 27(6):649-54. PubMed ID: 2214329
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects.
Heiss WD; Herholz K; Pawlik G; Hebold I; Klinkhammer P; Szelies B
Keio J Med; 1989 Jun; 38(2):111-35. PubMed ID: 2674513
[TBL] [Abstract][Full Text] [Related]
19. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.
Schapiro MB; Pietrini P; Grady CL; Ball MJ; DeCarli C; Kumar A; Kaye JA; Haxby JV
J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):859-64. PubMed ID: 8350100
[TBL] [Abstract][Full Text] [Related]
20. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.
Engler H; Lundberg PO; Ekbom K; Nennesmo I; Nilsson A; Bergström M; Tsukada H; Hartvig P; Långström B
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):85-95. PubMed ID: 12483414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
